This newsletter from the International Senologic and Oncologic Scientific Community provides updates on senology research and events. Apps are now available to access senology content on mobile devices. It summarizes recent research on reduced axillary spread in triple negative breast cancer, inherited mutations in breast cancer susceptibility genes, and risks of bone marrow disorders after breast cancer treatment. Upcoming conferences on breast cancer are announced and recent research on circadian disruption and breast cancer risk, melanoma treatment, selenium and colorectal cancer, and bisphosphonates for lung and breast cancer is briefly described.